![Brian R. Leyland-Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian R.
Leyland-Jones is the founder of Viviphi Ltd. (2015).
Dr. Leyland-Jones is currently the Director & Chief Medical Officer at Aim-Hi Accelerator Fund, Inc. Formerly, Dr. Leyland-Jones served as an Independent Director at Genta, Inc. Education includes a doctorate from the University of London.
| Società | Posizione | Inizio |
|---|---|---|
Aim-Hi Accelerator Fund, Inc.
 Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that supports startup oncology companies | Direttore Tecnico/Scientifico/R&S | - |
| Società | Posizione | Fine |
|---|---|---|
Viviphi Ltd.
 Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Fondatore | - |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 4 |
|---|---|
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Technology Services |
Aim-Hi Accelerator Fund, Inc.
Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that supports startup oncology companies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
